KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $32.03 $45.00 Friday, 26th Apr 2024 CRBP stock ended at $34.25. This is 2.24% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 7.30% from a day low at $32.27 to a day high of $34.63.
90 days $17.66 $49.87
52 weeks $3.03 $49.87

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
Jul 14, 2021 $1.60 $1.62 $1.56 $1.57 909 274
Jul 13, 2021 $1.63 $1.66 $1.58 $1.59 1 332 756
Jul 12, 2021 $1.70 $1.73 $1.64 $1.65 885 875
Jul 09, 2021 $1.69 $1.72 $1.65 $1.72 697 213
Jul 08, 2021 $1.66 $1.73 $1.64 $1.66 773 903
Jul 07, 2021 $1.73 $1.74 $1.62 $1.72 1 482 069
Jul 06, 2021 $1.77 $1.79 $1.66 $1.69 2 906 327
Jul 02, 2021 $1.80 $1.83 $1.76 $1.79 945 275
Jul 01, 2021 $1.82 $1.89 $1.80 $1.82 1 141 245
Jun 30, 2021 $1.84 $1.88 $1.80 $1.83 1 293 343
Jun 29, 2021 $1.91 $1.91 $1.84 $1.84 1 431 117
Jun 28, 2021 $1.91 $1.97 $1.86 $1.93 2 216 477
Jun 25, 2021 $1.92 $1.97 $1.84 $1.89 15 306 806
Jun 24, 2021 $1.68 $2.09 $1.61 $2.07 21 516 742
Jun 23, 2021 $1.92 $1.99 $1.90 $1.99 1 313 748
Jun 22, 2021 $1.95 $1.97 $1.85 $1.94 2 334 481
Jun 21, 2021 $1.99 $2.00 $1.90 $1.98 2 180 745
Jun 18, 2021 $2.04 $2.06 $1.97 $1.99 4 032 945
Jun 17, 2021 $2.11 $2.16 $2.04 $2.07 2 073 407
Jun 16, 2021 $2.04 $2.14 $2.01 $2.13 2 097 424
Jun 15, 2021 $2.11 $2.15 $2.04 $2.06 1 716 218
Jun 14, 2021 $2.17 $2.21 $2.12 $2.14 1 973 900
Jun 11, 2021 $2.17 $2.20 $2.14 $2.18 914 642
Jun 10, 2021 $2.18 $2.22 $2.14 $2.18 1 279 330
Jun 09, 2021 $2.22 $2.29 $2.17 $2.21 2 344 541
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT